|
|
||||||||
1 Division of Cardiology, Department of Internal Medicine, 2 Institute of Experimental Internal Medicine, 3 Institute of Pathology, 4 Department of Cardiovascular Surgery, and 5 Institute of Immunology, University Hospital Magdeburg, 39120 Magdeburg, Germany
Atrial fibrillation (AF) is accompanied
by intracellular calcium overload. The purpose of this study was to
assess the role of calcium-dependent calpains and cytokines during AF.
Atrial tissue samples from 32 patients [16 with chronic AF and 16 in sinus rhythm (SR)] undergoing open heart surgery were studied. Atrial
expression of calpain I and II, calpastatin, troponin T (TnT), troponin
C (TnC), and cytokines [interleukin (IL)-1
, IL-2, IL-6, IL-8,
IL-10, transforming growth factor (TGF)-
1, and tumor necrosis
factor-
] were determined. Expression of calpain I was increased
during AF (461 ± 201% vs. 100 ± 34%, P < 0.05). Amounts of calpain II and calpastatin were unchanged. Total
calpain enzymatic activity was more than doubled during AF (35.2 ± 17.7 vs. 12.4 ± 9.2 units, P < 0.05). In
contrast to TnC, TnT levels were reduced in fibrillating atria by 26%
(P < 0.05), corresponding to the myofilament
disintegration seen by electron microscopy. Small amounts of only IL-2
and TGF-
1 mRNA and protein were detected regardless of the
underlying cardiac rhythm. In conclusion, atria of patients with
permanent AF show evidence of calpain I activation that might
contribute to structural remodeling and contractile dysfunction,
whereas there is no evidence of activation of tissue cytokines.
fibrillation; calcium; contractile proteins; cytokine; inflammation
This article has been cited by other articles:
![]() |
G. Michael, L. Xiao, X.-Y. Qi, D. Dobrev, and S. Nattel Remodelling of cardiac repolarization: how homeostatic responses can lead to arrhythmogenesis Cardiovasc Res, February 15, 2009; 81(3): 491 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Liuba, H. Ahlmroth, L. Jonasson, A. Englund, A. Jonsson, K. Safstrom, and H. Walfridsson Source of inflammatory markers in patients with atrial fibrillation Europace, July 1, 2008; 10(7): 848 - 853. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dobrev and E. Wettwer Four and a half LIM protein 1: a novel chaperone for atrium-specific Kv1.5 channels with a potential role in atrial arrhythmogenesis Cardiovasc Res, June 1, 2008; 78(3): 411 - 412. [Full Text] [PDF] |
||||
![]() |
S. Nattel, B. Burstein, and D. Dobrev Atrial Remodeling and Atrial Fibrillation: Mechanisms and Implications Circ Arrhythmia Electrophysiol, April 1, 2008; 1(1): 62 - 73. [Full Text] [PDF] |
||||
![]() |
S. Nattel, A. Maguy, S. Le Bouter, and Y.-H. Yeh Arrhythmogenic Ion-Channel Remodeling in the Heart: Heart Failure, Myocardial Infarction, and Atrial Fibrillation Physiol Rev, April 1, 2007; 87(2): 425 - 456. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Lee, T. H. Everett IV, D. Rahmutula, J. M. Guerra, E. Wilson, C. Ding, and J. E. Olgin Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure Circulation, October 17, 2006; 114(16): 1703 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Goette and U. Schotten Inhibition of angiotensin II type 1 receptors reduces atrial stunning and spontaneous echo contrast after electrical cardioversion of atrial fibrillation Eur. Heart J., September 1, 2006; 27(17): 2034 - 2035. [Full Text] [PDF] |
||||
![]() |
W. Anne, R. Willems, T. Roskams, P. Sergeant, P. Herijgers, P. Holemans, H. Ector, and H. Heidbuchel Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation Cardiovasc Res, September 1, 2005; 67(4): 655 - 666. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hanna, S. Cardin, T.-K. Leung, and S. Nattel Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure Cardiovasc Res, August 1, 2004; 63(2): 236 - 244. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. G. Conway, P. Buggins, E. Hughes, and G. Y. H. Lip Relationship of interleukin-6 and C-Reactive protein to the prothrombotic state in chronic atrial fibrillation J. Am. Coll. Cardiol., June 2, 2004; 43(11): 2075 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Wasson, H. K. Reddy, and M. L. Dohrmann Current Perspectives of Electrical Remodeling and Its Therapeutic Implications Journal of Cardiovascular Pharmacology and Therapeutics, April 1, 2004; 9(2): 129 - 144. [Abstract] [PDF] |
||||
![]() |
S. Cardin, D. Li, N. Thorin-Trescases, T.-K. Leung, E. Thorin, and S. Nattel Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways Cardiovasc Res, November 1, 2003; 60(2): 315 - 325. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |